BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li YJ, Liu HT, Xue CJ, Xing XQ, Dong ST, Wang LS, Ding CY, Meng L, Dong ZJ. The synergistic anti-tumor effect of schisandrin B and apatinib. J Asian Nat Prod Res 2020;22:839-49. [PMID: 31364407 DOI: 10.1080/10286020.2019.1645131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Gao Q, Feng J, Liu W, Wen C, Wu Y, Liao Q, Zou L, Sui X, Xie T, Zhang J, Hu Y. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Adv Drug Deliv Rev 2022;188:114445. [PMID: 35820601 DOI: 10.1016/j.addr.2022.114445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 He L, Chen H, Qi Q, Wu N, Wang Y, Chen M, Feng Q, Dong B, Jin R, Jiang L. Schisandrin B suppresses gastric cancer cell growth and enhances the efficacy of chemotherapy drug 5-FU in vitro and in vivo. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fang CY, Lou DY, Zhou LQ, Wang JC, Yang B, He QJ, Wang JJ, Weng QJ. Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin 2021;42:1951-69. [PMID: 33750909 DOI: 10.1038/s41401-021-00620-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 28.0] [Reference Citation Analysis]
4 Zhang W, Wang W, Shen C, Wang X, Pu Z, Yin Q. Network pharmacology for systematic understanding of Schisandrin B reduces the epithelial cells injury of colitis through regulating pyroptosis by AMPK/Nrf2/NLRP3 inflammasome. Aging (Albany NY) 2021;13:23193-209. [PMID: 34628369 DOI: 10.18632/aging.203611] [Cited by in F6Publishing: 4] [Reference Citation Analysis]